✉news BusinessStartups first seen 5 h ago, last 5 h ago, peak #37
Aptadir raises €40M to advance demethylating medicines
Original: Aptadir has €40M warchest to advance demethylating medicines
Spanish biotech Aptadir has secured a €40 million funding package to advance its demethylating medicines, a class of therapies targeting epigenetic changes in cancer cells. The company says the new capital will support development of its pipeline of epigenetic drug candidates as it moves toward clinical progress.
Why now: Funding news in the biotech startup space typically draws attention from investors and industry watchers tracking oncology drug development.
Evidence
- Aptadir has €40M warchest to advance demethylating medicines · firstwordpharma.com
API: https://socialmediatrends-api.osmike.com/v1/trends/348625